Siegel RL, Giaquinto AN, and Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12–49. https://doi.org/10.3322/caac.21820.

Article  PubMed  Google Scholar 

Yang J, Huang J, Zhang Y, Zeng K, Liao M, Jiang Z, Bao W, and Lu Q (2023) Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis. Chin Med J (Engl) 136:2028–2036. https://doi.org/10.1097/cm9.0000000000002300.

Article  PubMed  Google Scholar 

Elsherif SB, Virarkar M, Javadi S, Ibarra-Rovira JJ, Tamm EP, and Bhosale PR (2020) Pancreatitis and PDAC: association and differentiation. Abdom Radiol (NY) 45:1324–1337. https://doi.org/10.1007/s00261-019-02292-w.

Article  PubMed  Google Scholar 

Ren S, Zhao R, Zhang J, Guo K, Gu X, Duan S, Wang Z, and Chen R (2020) Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 45:1524–1533. https://doi.org/10.1007/s00261-020-02506-6.

Article  PubMed  Google Scholar 

Ye Y, Zhang J, Song P, Qin P, Hu Y, An P, Li X, Lin Y, Wang J, and Feng G (2023) Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis. Technol Cancer Res Treat 22:15330338231180792. https://doi.org/10.1177/15330338231180792.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Seufert I, Al-Shaheri FN, Kurilov R, Bauer AS, Manoochehri M, Moskalev EA, Brors B, Tjaden C, Giese NA, et al. (2023) DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma. Gut 72:2344–2353. https://doi.org/10.1136/gutjnl-2023-330155.

Article  CAS  PubMed  Google Scholar 

Altinkaya E, Akay E, Koc A, and Caglar E (2024) EUS-FNA Biopsy for Pancreatic Mass. J Coll Physicians Surg Pak 34:832–837. https://doi.org/10.29271/jcpsp.2024.07.832.

Article  PubMed  Google Scholar 

Jia WY, Gui Y, Chen XQ, Tan L, Zhang J, Xiao MS, Chang XY, Dai MH, Guo JC, Cheng YJ, et al. (2024) Efficacy of color Doppler ultrasound and contrast-enhanced ultrasound in identifying vascular invasion in pancreatic ductal adenocarcinoma. Insights Imaging 15:181. https://doi.org/10.1186/s13244-024-01779-5.

Article  PubMed  PubMed Central  Google Scholar 

Lin XJ, Zhu S, Wang D, Chen JY, Wei SX, Chen SY, and Luo HC (2024) Correlation of dynamic contrast-enhanced ultrasonography and the Ki-67 labelling index in pancreatic ductal adenocarcinoma. World J Gastroenterol 30:4697–4708. https://doi.org/10.3748/wjg.v30.i44.4697.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, Bertolotto M, Calliada F, Clevert DA, Cosgrove D, et al. (2018) The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med 39:e2-e44. https://doi.org/10.1055/a-0586-1107.

Article  PubMed  Google Scholar 

Shimizu K, Ito T, Irisawa A, Ohtsuka T, Ohara H, Kanno A, Kida M, Sakagami J, Sata N, Takeyama Y, et al. (2022) Evidence-based clinical practice guidelines for chronic pancreatitis 2021. J Gastroenterol 57:709–724. https://doi.org/10.1007/s00535-022-01911-6.

Article  PubMed  PubMed Central  Google Scholar 

Gardner TB, Adler DG, Forsmark CE, Sauer BG, Taylor JR, and Whitcomb DC (2020) ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol 115:322–339. https://doi.org/10.14309/ajg.0000000000000535.

Article  PubMed  Google Scholar 

Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim MH, Klöppel G, Lerch MM, Löhr M, et al. (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352–358. https://doi.org/10.1097/MPA.0b013e3182142fd2.

Article  PubMed  Google Scholar 

Phoa SS, Reeders JW, Stoker J, Rauws EA, Gouma DJ, and Laméris JS (2000) CT criteria for venous invasion in patients with pancreatic head carcinoma. Br J Radiol 73:1159–1164. https://doi.org/10.1259/bjr.73.875.11144792.

Article  CAS  PubMed  Google Scholar 

Tong T, Gu J, Xu D, Song L, Zhao Q, Cheng F, Yuan Z, Tian S, Yang X, Tian J, et al. (2022) Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis. BMC Med 20:74. https://doi.org/10.1186/s12916-022-02258-8.

Article  PubMed  PubMed Central  Google Scholar 

Stoffel EM, Brand RE, and Goggins M (2023) Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Gastroenterology 164:752–765. https://doi.org/10.1053/j.gastro.2023.02.012.

Article  PubMed  Google Scholar 

Munigala S, Kanwal F, Xian H, and Agarwal B (2014) New diagnosis of chronic pancreatitis: risk of missing an underlying pancreatic cancer. Am J Gastroenterol 109:1824–1830. https://doi.org/10.1038/ajg.2014.318.

Article  PubMed  Google Scholar 

Xu C, Jun E, Okugawa Y, Toiyama Y, Borazanci E, Bolton J, Taketomi A, Kim SC, Shang D, Von Hoff D, et al. (2024) A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma. Gastroenterology 166:178–190.e116. https://doi.org/10.1053/j.gastro.2023.09.050.

Article  CAS  PubMed  Google Scholar 

Janga LSN, Sambe HG, Yasir M, Man RK, Gogikar A, Nanda A, and Mohammed L (2023) Holistic Understanding of the Role of Carbohydrate Antigen 19– 9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. Cureus 15:e44382. https://doi.org/10.7759/cureus.44382.

Article  PubMed  Google Scholar 

Huang J, Yang J, Ding J, Zhou J, Yang R, Li J, Luo Y, and Lu Q (2022) Development and validation of an ultrasound-based prediction model for differentiating between malignant and benign solid pancreatic lesions. Eur Radiol 32:8296–8305. https://doi.org/10.1007/s00330-022-08930-0.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Meng Y, Li Q, Yu J, Liu F, Fang X, Li J, Feng X, Zhou J, Zhu M, et al. (2022) Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis. Eur Radiol 32:6336–6347. https://doi.org/10.1007/s00330-022-08698-3.

Article  PubMed  Google Scholar 

Liu J, Hu L, Zhou B, Wu C, and Cheng Y (2022) Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis. Transl Oncol 18:101357. https://doi.org/10.1016/j.tranon.2022.101357.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan Z, Li Y, Yan K, Wu W, Yin S, Yang W, Xing B, Li X, and Zhang X (2013) Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions–a comparison of conventional ultrasound and contrast-enhanced CT. Eur J Radiol 82:1385–1390. https://doi.org/10.1016/j.ejrad.2013.04.016.

Article  PubMed  Google Scholar 

Wang Y, Li G, Yan K, Fan Z, Long R, Shan J, Dai Y, and Wu W (2022) Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions. Eur Radiol 32:2060–2069. https://doi.org/10.1007/s00330-021-08243-8.

Article  PubMed  Google Scholar 

Qiu YJ, Zhao GC, Shi SN, Zuo D, Zhang Q, Dong Y, Lou WH, and Wang WP (2022) Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Clin Hemorheol Microcirc 81:149–161. https://doi.org/10.3233/ch-221390.

Article  CAS  PubMed  Google Scholar 

Wang L, Nie F, Dong T, Li M, Li Y, and Yin C (2023) Role of contrast-enhanced ultrasound with time-intensity curve analysis for differentiating hypovascular solid pancreatic lesions. Eur Radiol 33:4885–4894. https://doi.org/10.1007/s00330-023-09393-7.

Article  PubMed  Google Scholar 

Cao H, Fan Q, Zhuo S, Qi T, Sun H, Rong X, Xiao X, Zhang W, Zhu L, and Wang L (2022) The Value of Chinese Thyroid Imaging Report and Data System Combined With Contrast-Enhanced Ultrasound Scoring in Differential Diagnosis of Benign and Malignant Thyroid Nodules. J Ultrasound Med 41:1753–1761. https://doi.org/10.1002/jum.15858.

Article  PubMed  Google Scholar 

Qiu S, Ding J, Wang Y, Zhou H, Zhao L, Zhao L, Zhou Y, Fu Y, and Jing X (2024) Dynamic Contrast-Enhanced Ultrasonography Combined With LR-M Classification Criteria for Differentiating Malignant Liver Nodules at High Risk for Hepatocellular Carcinoma. Ultrasound Med Biol 50:1028–1033. https://doi.org/10.1016/j.ultrasmedbio.2024.03.016.